Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Sep 21, 2010


Gentel Biosciences last week launched a menu of new APiX Human Tumor Profiling Kits. The kits, which contain tissue-lysate protein arrays and chromogenic-based detection reagents, are suitable for the testing of putative protein biomarkers in over 13 cancer subtypes, according to the firm.

Gentel's kits combine its APiX chromogenic detection technology and Protein Biotechnologies' collection of normal and diseased human tissue for the study of protein expression differences in patient sample sets. Arrays are available to study human breast, colon, female reproductive tract, larynx and skin, liver, lung, prostate and testes, stomach, thyroid, ovary, kidney, bone marrow, and bladder tissues.

Each kit is configured for use with Gentel's Proteomics Multi-System and AthenaQuant analysis software.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.